No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Observational Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Anticholesteremic Agents / administration & dosage*
-
Aorta / diagnostic imaging
-
Aorta / drug effects*
-
Aorta / metabolism
-
Aortic Diseases / blood
-
Aortic Diseases / diagnostic imaging
-
Aortic Diseases / drug therapy*
-
Biomarkers / blood
-
Carotid Arteries / diagnostic imaging
-
Carotid Arteries / drug effects*
-
Carotid Arteries / metabolism
-
Carotid Artery Diseases / blood
-
Carotid Artery Diseases / diagnostic imaging
-
Carotid Artery Diseases / drug therapy*
-
Cholesterol, LDL / blood
-
Drug Administration Schedule
-
Dyslipidemias / blood
-
Dyslipidemias / diagnosis
-
Dyslipidemias / diagnostic imaging*
-
Female
-
Fluorodeoxyglucose F18 / administration & dosage
-
Greece
-
Humans
-
Inflammation Mediators / blood
-
Male
-
Middle Aged
-
PCSK9 Inhibitors*
-
Positron Emission Tomography Computed Tomography
-
Predictive Value of Tests
-
Prospective Studies
-
Radiopharmaceuticals / administration & dosage
-
Time Factors
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Anticholesteremic Agents
-
Biomarkers
-
Cholesterol, LDL
-
Inflammation Mediators
-
PCSK9 Inhibitors
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18
-
PCSK9 protein, human
-
evolocumab
-
alirocumab